Communiqués China Pharma Holdings, Inc.

Actions

CPHI

US16941T3023

Marché Fermé - Nyse Autres places de cotation 22:10:00 01/07/2024			Varia. 5j.	Varia. 1 janv.
0,2475 ^USD	-0,40%		-6,43%	-59,09%

15/05	China Pharma Holdings, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
01/04	China Pharma Holdings, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

CHINA PHARMA HOLDINGS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	20/04/23	AQ
CHINA PHARMA HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	30/03/23	AQ
China Pharma : Current Report - Form 8-K	29/03/23	PU
CHINA PHARMA HOLDINGS, INC. : Other Events (form 8-K)	29/03/23	AQ
CHINA PHARMA HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	24/02/23	AQ
CHINA PHARMA HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	30/12/22	AQ
China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask	29/12/22	AQ
China Pharma : Dec. 28, 2022_China Pharma Holdings, Inc. Announced the Launch of N95 Medical Pr	29/12/22	PU
China Pharma : Dec. 5, 2022_China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Di	06/12/22	PU
CHINA PHARMA HOLDINGS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	02/12/22	AQ
CHINA PHARMA HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	02/12/22	AQ
CHINA PHARMA HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	14/11/22	AQ
CHINA PHARMA HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	30/09/22	AQ
CHINA PHARMA HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	11/08/22	AQ
China Pharma : Announces Receipt of Noncompliance Notice from NYSE American - Form 8-K	23/06/22	PU
CHINA PHARMA HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	22/06/22	AQ
CHINA PHARMA HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	12/05/22	AQ
CHINA PHARMA HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	30/03/22	AQ
China Pharma : Submission of Matters to a Vote of Security Holders - Form 8-K	29/12/21	PU
CHINA PHARMA HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	29/12/21	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués China Pharma Holdings, Inc.

Actions

CPHI

US16941T3023

Communiqués

Filtres